Skip to main content
. 2018 Sep 4;10:3193–3198. doi: 10.2147/CMAR.S167114

Table 3.

Distribution of DC-SIGNR neck region genotypes and alleles in NPC patients and controls

Genotype/allelea Controls (n) Cases (n) P
5/5 28 (5.0) 15 (3.1) 0.927b
6/5 13 (2.3) 9 (1.9)
6/6 4 (0.7) 1 (0.2)
9/5 10 (1.8) 13 (2.7)
9/6 6 (1.1) 9 (1.9)
9/9 13 (2.3) 15 (3.1)
7/5 110 (19.6) 83 (17.4) 0.362c
7/6 62 (11.1) 41 (8.6) 0.187c
7/7 206 (36.7) 183 (38.4) 0.585c
9/7 109 (19.4) 108 (22.7) 0.205c
Total 561 477
5 189 (16.8) 135 (14.1) 0.092c
6 89 (7.9) 61 (6.4) 0.177c
7 693 (61.8) 598 (62.7) 0.667c
9d 151 (13.5) 160 (16.8) 0.035c
Total 1,122 954

Notes: Values are n (%).

a

The number refers to the number of neck region repeats encoded by each genotype or allele.

b

Chi-squared test for the merged group of 5/5, 6/5, 6/6, 9/5, 9/6, 9/9, each genotype frequency of which is <5%.

c

Chi-squared test.

d

P<0.05. The significant value is shown in bold.

Abbreviations: DC-SIGNR, dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin-related; NPC, nasopharyngeal carcinoma.